Abnormally Expressed lncRNAs as Potential Biomarkers for Gastric Cancer Risk: A Diagnostic Meta-Bioinformatics Analysis

Table 5

Diagnostic efficacy of lncRNAs.

	AUC	(95% CI)		SEN	SPE	YI	Cut-off
lncRNA
PVT1	0.949	(0.922, 0.976)	<0.01	0.808	0.969	0.777	0.8616
HOTAIR	0.942	(0.917, 0.967)	<0.01	0.891	0.906	0.797	0.0016
KRT18P55	0.890	(0.834, 0.947)	<0.01	0.765	0.906	0.671	0.0022
C5orf66-AS1	0.853	(0.790, 0.915)	<0.01	0.739	0.875	0.614	0.0218
UCA1	0.788	(0.713, 0.863)	<0.01	0.696	0.750	0.446	0.0855
AC064834.1	0.785	(0.720, 0.851)	<0.01	0.691	0.875	0.566	0.0001
HULC	0.754	(0.681, 0.827)	<0.01	0.608	0.844	0.452	0.0003
LINC00086	0.754	(0.678, 0.830)	<0.01	0.667	0.812	0.479	0.0867
H19	0.708	(0.610, 0.805)	<0.01	0.651	0.719	0.37	1.2771
Combined model
PVT1+C5orf66-AS1	0.972	(0.951-0.992)	<0.01	0.941	0.937	0.878	0.7771